Skip to main content
. Author manuscript; available in PMC: 2019 Mar 21.
Published in final edited form as: Bioconjug Chem. 2017 Dec 27;29(3):604–612. doi: 10.1021/acs.bioconjchem.7b00692

Figure 1.

Figure 1

Schematic of nanoparticle-based vaccine delivery and transport. Upon administration via the commonly employed subcutaneous route of delivery, the small size of the nanoparticles enables efficient drainage and transport to the lymph nodes. Here, the nanoparticles can deliver their payloads to activate the resident immune cells (i.e. dendritic cells, T cells, and B cells) and promote immunity.